Oesophageal stents with anti-reflux valve for treatment of tumour of the oesophageal junction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN83742179

Enrollment

Registered

2004-09-30

Start date

2003-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Oesophageal Cancer Oesophageal

Interventions

Please note that this trial was stopped as the devices to be used were no longer available. All patients will have stents inserted according to integrated care pathway, the only difference from stand

Eligibility

Inclusion criteria

Inclusion criteria: 25 patients in each arm. 50 consecutive patients to be recruited after a positive decision for stent insertion has been made - all patients with a tumour site at or extending to the gastro-oesophageal (GO)-junction

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Development of gastro-oesophageal reflux symptoms requiring treatment	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026